Tenet Announces Chief Financial Officer Transition - Seite 2

“I am excited to join Tenet Healthcare, a leading healthcare services company with a track record for growth and value creation,” said Sun Park. “I am looking forward to building upon the strong financial foundation to further the Company’s continued performance.”

About Sun Park

Before joining the Company, Sun Park was the Executive Vice President and Group Chief Financial Officer for Pharmaceutical Distribution and Strategic Global Sourcing of AmerisourceBergen, a Fortune 10 global pharmaceutical sourcing and distribution services company. Mr. Park has served in leadership roles at AmerisourceBergen, since joining in 2012, across finance, data & analytics, corporate strategy and development, and pharmaceutical manufacturer relationships. Previously, Mr. Park served in various leadership roles at MedImmune, a global biotechnology company, at AstraZeneca, and at Merrill Lynch & Company. Mr. Park has a B.A. in Mathematical Economics and Molecular Biology from Yale University and a M.A. in Biotechnology from Johns Hopkins University.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates or has ownership interests in more than 465 ambulatory surgery centers and surgical hospitals. We also operate 61 acute care and specialty hospitals, approximately 110 other outpatient facilities, a network of leading employed physicians and a global business center in Manila, Philippines. Our Conifer Health Solutions subsidiary provides revenue cycle management and value-based care services to hospitals, health systems, physician practices, employers, and other clients. Across the Tenet enterprise, we are united by our mission to deliver quality, compassionate care in the communities we serve. For more information, please visit www.tenethealth.com.

Cautionary Statement

This release contains “forward-looking statements” - that is, statements that relate to future, not past, events. In this context, forward-looking statements often address the Company’s expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “assume,” “believe,” “budget,” “estimate,” “forecast,” “intend,” “plan,” “predict,” “project,” “seek,” “see,” “target,” or “will.” Forward-looking statements by their nature address matters that are, to different degrees, uncertain, especially with regards to developments related to COVID-19. Particular uncertainties that could cause the Company’s actual results to be materially different than those expressed in the Company’s forward-looking statements include, but are not limited to, the impact of the COVID-19 pandemic and other factors disclosed under “Forward-Looking Statements” and “Risk Factors” in our Form 10-K for the year ended December 31, 2022, subsequent Form 10-Q filings and other filings with the Securities and Exchange Commission.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230622990419/en/

The Tenet Healthcare Stock at the time of publication of the news with a raise of +1,40 % to 71,50USD on Tradegate stock exchange (22. Juni 2023, 22:26 Uhr).